Preparation and Cytotoxicity of Imiquimod-Loaded Solid Lipid Nanoparticles
暂无分享,去创建一个
N. Gu | Q. Xia | Huafeng Zhou | Xu Miao | D. Luo | Yangyan Lu | Q. Ma
[1] V. Venkateswarlu,et al. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[2] C. Xie,et al. The production and characteristics of solid lipid nanoparticles (SLNs). , 2003, Biomaterials.
[3] S Diot,et al. A prevalidation study on the in vitro skin irritation function test (SIFT) for prediction of acute skin irritation in vivo: results and evaluation of ECVAM Phase III. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.
[4] R. Müller,et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. , 2002, Advanced drug delivery reviews.
[5] Aditya K. Gupta,et al. Imiquimod: A Review , 2002, Journal of cutaneous medicine and surgery.
[6] A. Thünemann,et al. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. , 2000, International journal of pharmaceutics.
[7] K. Westesen,et al. Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles , 1994 .
[8] J. Yano,et al. Molecular interactions and kinetic properties of fats. , 1999, Progress in lipid research.
[9] R. Müller,et al. Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery , 1995 .